join retatrutide trial 💉 may be redefining obesity treatment. New data from TRIUMPH-1 showed: 🔥 ~28% average weight loss over 80 weeks 🔥 >30% weight loss in nearly half of participant #ObesityMedicine #Retatrutide #GLP1 #CardioMetabolic Experimental drug retatrutide cut weight

Adding a copper-containing peptide to this population without monitoring creates a compounding risk that is entirely avoidable with baseline labs

Vijay S, Brassier A, Ghosh A, Fecarotta S, Abel F, Marulkar S, Jones SA

The intracellular domain is constituted of a juxta membrane domain, involved in the receptor down-regulation, a tyrosine kinase domain, involved in signal transduction, and a C-terminal regulatory tail [50]

Low Self-Esteem or Body Image Issues Women who feel self-conscious about their appearance or weight may withdraw from intimacy

Reduced Inflammation: Long-term use may help reduce chronic inflammation, which is often associated with obesity and related diseases, promoting better overall health

doi: 10.1177/1535370221995785 183